Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    FDA Seeks Proposals for Advancing Regulatory Science

    By Global Biodefense StaffMarch 18, 2014
    Share
    Facebook LinkedIn Reddit Email
    FDA - Advancing Regulatory Science

    The U.S. Food and Drug Administration (FDA) is soliciting proposals for advanced research and development to support regulatory science. The purpose of the Broad Agency Announcement (BAA) is to utilize industry capabilities to advance the state of the art and achieve improvements in technology, materials, processes, methods, devices, or techniques important to the FDA mission.

    Highlighted topic areas include:

    • Development of Medical Countermeasures to Protect Against Threats
    • Modernize Toxicology to Enhance Product Safety
    • Identify and Evaluate Biomarkers for Use in Non-Clinical and Clinical Evaluations
    • Stimulate Innovation in Clinical Evaluations and Personalized Medicine
    • Reduce Risk of Microbial Contamination of Products
    • Support New Approaches to Improve Product Manufacturing and Quality
    • Ensure FDA Readiness to Evaluate Innovative Emerging Technologies
    • Harness Diverse Data through Information Sciences to Improve Health Outcomes
    • Implement a New Prevention-Focused Food Safety System to Protect Public Health
    • Strengthening Social and Behavioral Science at FDA
    • Strengthening the Global Product Safety Net

    The BAA was originally announced in May 2013 with a one year window for proposal submission. The FDA has recently amended the solicitation to add the following topics of interest:

    Studies to increase the safety of post approval drug use

    Develop innovative methods to better understand and reduce the occurrence of adverse events in post market use of drugs. Examples include but are not limited to: hypoglycemia in certain patient populations; serious bleeding in patients on anticoagulants; and patients in chronic pain on opioid therapy. Approaches could include the use of innovative messaging strategies, electronic health records, mobile technologies, clinical studies, or educational campaigns.

    Improve scientific approaches to evaluate generic drugs

    In July 2012, Congress passed the Generic Drug User Fee Amendments (Title III of the Food and Drug Administration Safety and Innovation Act). The Generic Drug User Fee Amendments (GDUFA) is designed to enhance public access to safe, high-quality generic drugs, and to reduce costs to industry. To support this goal, FDA agreed in the GDUFA commitment letter to consult with industry and the public in order to create an annual list of regulatory science initiatives specific to research on generic drugs for each year covered by GDUFA. The research activities related to the FY 2014 topic areas are as follows:

    • Develop surveillance and monitoring methods for generic drugs.
    • Understand patient perceptions of generic drug quality and effectiveness.
    • Evaluate and verify therapeutic equivalence via brand to generic switching studies in patients for anti-epileptic drugs, immunosuppressant drugs, bupropion, ADHD drugs and cardiovascular drugs.

    Further details are available under Solicitation Number: FDA BAA-13-00119.

    BAA Biomarkers
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNIH Scientists Track Evolution of a Superbug
    Next Article DoD Improvements to Medical Countermeasure Acquisitions

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.